Author: Sree Roy

Xyrem Sales Up 34% in 2014

“2014 was an outstanding year for Jazz Pharmaceuticals as we executed on our growth strategy, delivered strong sales of our key products and further diversified our product portfolio, and expanded our development pipeline...

Read More